Weimin Yu

March 11, 2024

Comprehensive analysis indicated that NDE1 is a potential biomarker for pan‐cancer and promotes bladder cancer progression

Abstract Background: The nuclear distribution E homologue 1 (NDE1) is a crucial dynein binding partner. The NDE1 protein has the…

October 30, 2023

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker

Abstract Background: X-C Motif Chemokine Ligand 2 (XCL2) is a 114 amino acid, structurally conserved chemokine involved in activating cytotoxic…

September 11, 2023

Prognostic and immunological roles of IL18RAP in human cancers

Abstract Across several cancers, IL18 receptor accessory protein (IL18RAP) is abnormally expressed, and this abnormality is related to tumor immunity…